Abbott (ABT) Q1 Earnings Beat Estimates

Core Viewpoint - Abbott reported quarterly earnings of $1.09 per share, exceeding the Zacks Consensus Estimate of $1.07 per share, and showing an increase from $0.98 per share a year ago, indicating a positive earnings surprise of 1.87% [1][2] Financial Performance - The company posted revenues of $10.36 billion for the quarter ended March 2025, which was below the Zacks Consensus Estimate by 0.56%, but up from $9.96 billion year-over-year [2] - Over the last four quarters, Abbott has surpassed consensus EPS estimates three times and topped revenue estimates twice [2] Stock Performance - Abbott shares have increased approximately 11.6% since the beginning of the year, contrasting with the S&P 500's decline of -8.3% [3] Future Outlook - The company's earnings outlook is crucial for investors, with current consensus EPS estimates at $1.25 for the coming quarter and $5.15 for the current fiscal year, alongside expected revenues of $11 billion and $44.42 billion respectively [7] - The estimate revisions trend for Abbott is currently mixed, resulting in a Zacks Rank 3 (Hold), suggesting shares are expected to perform in line with the market in the near future [6] Industry Context - The Medical - Products industry, to which Abbott belongs, is currently ranked in the bottom 25% of over 250 Zacks industries, indicating potential challenges ahead [8]